Valion Bio, Inc. (VBIO) Return on equity 2021–2024
Valion Bio, Inc. (VBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-223.1%FY2024 · since FY2021: -64.0% → -223.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -223.1% | +7.2 pp |
| FY2023 | -230.3% | +47.8 pp |
| FY2022 | -278.1% | -214.1 pp |
| FY2021 | -64.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net incomeVBIO Net marginVBIO Gross profitVBIO Gross marginVBIO Operating incomeVBIO Operating marginVBIO Operating cash flowVBIO Free cash flowVBIO Capital expendituresVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →